Papakostas G.I., Shelton R.C., Kinrys G., Henry M.E., Bakow B.R., Lipkin S.H., Pi B., Thurmond L., Bilello J.A. Assessment of a multi-assay, serum-based biological ...

A new way to quickly detect depression is causing a literal spit take. Trusting a depressed brain to self-diagnose is like asking a broken GPS if you’re lost. While it might seem obvious, depression ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

A woman walks into a clinic for a routine blood draw. Weeks later, a lab report flags something unexpected: the immune cells ...

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies that included 3,532 ...

A depression drug candidate that’s a key part of Johnson & Johnson’s neuroscience strategy has failed a Phase 3 clinical trial, the latest dose of disappointing news for an emerging class of medicines ...

Patients with chronic conditions who are failing on conventional therapies may be suffering from undiagnosed major depression ...